Mycobacterium tuberculosis having resistance to rifampicin, isoniazid, and pyrazinamide is described as –
**Core Concept:**
Mycobacterium tuberculosis is the causative agent of Tuberculosis (TB), a global public health concern. TB primarily affects the lungs and can lead to severe respiratory complications. Drug resistance in TB refers to Mycobacterium tuberculosis strains that are resistant to multiple anti-tuberculosis drugs. Drug-resistant TB is categorized based on the specific drugs involved.
**Why the Correct Answer is Right:**
The correct answer is **D.** MDR (Multi-Drug Resistant) TB is defined as Mycobacterium tuberculosis that is resistant to at least rifampicin and isoniazid. These two drugs are considered first-line drugs for TB treatment due to their bactericidal action against the bacteria. Rifampicin is a rifamycin antibiotic that targets the bacterial RNA polymerase, inhibiting transcription and ultimately leading to bacteria death. Isoniazid is an hydrazine compound that inhibits mycobacterial enzymes involved in the synthesis of mycolic acids, thus disrupting the cell wall synthesis and causing bacterial death.
**Why Each Wrong Option is Incorrect:**
A. TB drug resistance involving only one drug (monoresistance) is not the focus of this question.
B. TB drug resistance involving two drugs other than rifampicin and isoniazid is also not the focus of this question.
C. TB drug resistance involving three drugs other than rifampicin, isoniazid, and pyrazinamide is not the focus of this question.
**Clinical Pearl:**
Understanding drug resistance patterns in tuberculosis is crucial for choosing appropriate treatment regimens. MDR-TB requires a more complex and lengthy treatment plan than standard TB treatment. This emphasizes the need for proper diagnosis and monitoring of TB drug resistance to ensure successful treatment outcomes and reduce the risk of drug resistance emergence.